Wikidata entity: Q670131
C₂₅H₃₈O₅ (P274)
Quantities
| P4250 | defined daily dose | 30 |
| P2067 | mass | 418.272 |
| P3780 | active ingredient in | ... | Q47521617 (Flolipid) | Flolipid |
| P3780 | active ingredient in | ... | Q47522351 (Zocor) | Zocor |
| P233 | canonical SMILES | String | CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C | ??? |
| P373 | Commons category | String | Simvastatin | ??? |
| P703 | found in taxon | ... | Q10598490 (Neosartorya udagawae) | Neosartorya udagawae |
| P703 | found in taxon | ... | Q60520493 (Aspergillus udagawae) | Aspergillus udagawae |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83283320 (LiverTox toxicity likelihood category A) | LiverTox toxicity likelihood category A |
| P2175 | medical condition treated | ... | Q184559 (arteriosclerosis) | arteriosclerosis |
| P2175 | medical condition treated | ... | Q844935 (coronary artery disease) | coronary artery disease |
| P2175 | medical condition treated | ... | Q1467339 (hypertriglyceridemia) | hypertriglyceridemia |
| P2175 | medical condition treated | ... | Q1827605 (lipedema) | lipedema |
| P2175 | medical condition treated | ... | Q18554145 (familial hyperlipidemia) | familial hyperlipidemia |
| P361 | part of | ... | Q22274484 (response to simvastatin) | response to simvastatin |
| P129 | physically interacts with | ... | Q415607 (3-hydroxy-3-methylglutaryl-CoA reductase) | 3-hydroxy-3-methylglutaryl-CoA reductase |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P3489 | pregnancy category | ... | Q28123619 (US pregnancy category X) | US pregnancy category X |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q326224 ((S)-(−)-colchicine) | (S)-(−)-colchicine |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q384295 (gemfibrozil) | gemfibrozil |
| P769 | significant drug interaction | ... | Q407883 (ketoconazole) | ketoconazole |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q410412 (carbamazepin) | carbamazepin |
| P769 | significant drug interaction | ... | Q411229 (itraconazole) | itraconazole |
| P769 | significant drug interaction | ... | Q411347 (amlodipine) | amlodipine |
| P769 | significant drug interaction | ... | Q411478 (fluconazole) | fluconazole |
| P769 | significant drug interaction | ... | Q418747 ((2R)-daptomycin) | (2R)-daptomycin |
| P769 | significant drug interaction | ... | Q419652 (danazol) | danazol |
| P769 | significant drug interaction | ... | Q419724 (fenofibrate) | fenofibrate |
| P769 | significant drug interaction | ... | Q422198 (amprenavir) | amprenavir |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q422585 (lopinavir) | lopinavir |
| P769 | significant drug interaction | ... | Q411588 (eltrombopag) | eltrombopag |
| P769 | significant drug interaction | ... | Q416632 (nefazodone) | nefazodone |
| P769 | significant drug interaction | ... | Q422618 (ritonavir) | ritonavir |
| P769 | significant drug interaction | ... | Q422654 (saquinavir) | saquinavir |
| P769 | significant drug interaction | ... | Q423366 (nelfinavir) | nelfinavir |
| P769 | significant drug interaction | ... | Q423404 (tipranavir) | tipranavir |
| P769 | significant drug interaction | ... | Q423467 (atazanavir) | atazanavir |
| P769 | significant drug interaction | ... | Q577387 (bezafibrate) | bezafibrate |
| P769 | significant drug interaction | ... | Q906453 (posaconazole) | posaconazole |
| P769 | significant drug interaction | ... | Q907104 (ranolazine) | ranolazine |
| P769 | significant drug interaction | ... | Q2736135 (telithromycin) | telithromycin |
| P769 | significant drug interaction | ... | Q3496452 (ciprofibrate) | ciprofibrate |
| P769 | significant drug interaction | ... | Q3765251 (darunavir) | darunavir |
| P769 | significant drug interaction | ... | Q5138908 (cobicistat) | cobicistat |
| P769 | significant drug interaction | ... | Q5908266 (idelalisib) | idelalisib |
| P3364 | stereoisomer of | ... | Q27166395 ([(1S,3R,7S,8R,8aS)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate) | [(1S,3R,7S,8R,8aS)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate |
| P279 | subclass of | ... | Q954845 (statin) | statin |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q954845 (statin) | statin |
| P2868 | subject has role | ... | Q955332 (hypolipidemic) | hypolipidemic |
| P2868 | subject has role | ... | Q50429847 (anticholesteremic agents) | anticholesteremic agents |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | simvastatin | ??? |
Why not click here or view trends?
log id: 3710076